for the Department of Defense (DoD), Duchenne Muscular Dystrophy Research Program (DMDRP), Peer Reviewed Medical Research Program (PRMRP), Peer Reviewed Orthopaedic Research Program (PRORP), and Prostate Cancer Research Program (PCRP) being managed by the office of Congressionally Directed Medical Research Programs (CDMRP).

Notices

• Impact of Washington, DC Area Federal Office Operating Status on NIH Grant Application Due Dates
  (NOT-OD-17-041)
  National Institutes of Health
• Gulf War Illness Research Program
  Award Opportunities: Biorepository Resource Network, Clinical Consortium, Investigator-Initiated and Qualitative Research
• Peer Reviewed Cancer Research Program
  Award Opportunities: Idea Award with Special Focus, Translational Team Science
• Additional Change to the NIH/AHRQ/NIOSH Policy on Post-Submission Materials
  (NOT-OD-17-066)
  National Institutes of Health
  Agency for Healthcare Research and Quality
  National Institute for Occupational Safety and Health
• Reminder: Authentication of Key Biological and/or Chemical Resources
  (NOT-OD-17-068)
  National Institutes of Health
  Agency for Healthcare Research and Quality
• High-Risk, High-Reward Research Program
  The NIH Common Fund announces FY 2018 funding opportunities for the NIH Director’s Pioneer, New Innovator, Transformative Research, and Early Independence Awards

Requests for Applications

• HIV pathogenesis and the oral microbiota (R01)
  (RFA-DE-18-007)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): November 24, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.

Program Announcements

• Zika Virus (ZIKV) Complications (R21)
  (PA-17-085)
  Eunice Kennedy ShriverNational Institute of Child Health and Human Development
  National Eye Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01)
  (PAR-17-123)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Perception and Cognition Research to Inform Cancer Image Interpretation (R21)
  (PAR-17-124)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt/Submission Date(s): May 30, 2017; September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Perception and Cognition Research to Inform Cancer Image Interpretation (R01)
  (PAR-17-125)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt/Submission Date(s): May 30, 2017; September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
• Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)
  (PAR-17-128)
  National Cancer Institute
  Application Receipt/Submission Date(s): May 9, 2017; September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019;May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01)
  (PAR-17-129)
  National Cancer Institute
  Application Receipt/Submission Date(s): May 9, 2017; September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019;May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
• Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)
  (PA-17-147)
  National Institute of Mental Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42)
  (PA-17-148)
  National Institute of Mental Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative HealthNational Cancer Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21)
  (PAR-17-150)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt/Submission Date(s): May 22, 2017, April 4, 2018, April 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01)
  (PAR-17-151)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt/Submission Date(s): May 22, 2017, April 4, 2018, April 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Advancing Our Understanding of the Brain Epitranscriptome (R21)
  (PAR-17-152)
  National Institute of Mental Health
  Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Advancing our Understanding of the Brain Epitranscriptomics (R01)
  (PAR-17-153)
  National Institute of Mental Health
  Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIDCR Prospective Observational or Biomarker Clinical Validation Study Cooperative Agreement (U01)
  (PAR-17-154)
  National Institute of Dental and Craniofacial Research
  Application Receipt/Submission Date(s): First receipt date, April 14, 2017, for all application types. Subsequently, Standard dates apply, by 5:00 PM local time
• Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01)
  (PA-17-155)
  National Institute on Drug Abuse
  Application Receipt/Submission Date(s): Standard dates , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R21)
  (PA-17-157)
  National Institute on Drug Abuse
  Application Receipt/Submission Date(s): Standard dates , by 5:00 PM local time of applicant organization. All types of non-AIDS applicationsallowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33)
  (PAR-17-149)
  National Center for Complementary and Integrative Health
  Application Receipt/Submission Date(s): New and revision applications are due June 1, 2017; February 1, 2018; October 1, 2018; May 31, 2019 , by 5:00 PM local time of applicant organization. Resubmission applications are due on June 20, 2017; February 14, 2018; October 17, 2018; June 14, 2019.
• Evaluating the NIDA Standardized Research E-Cigarette in Risk Reduction and Related Studies (U01)
  (PAR-17-156)
  National Institute on Drug Abuse
  Application Receipt/Submission Date(s): April 24, 2017; April 24, 2018; April 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Secondary Data Analyses to Explore NIMH Research Domain Criteria (R03)
  (PAR-17-158)
  National Institute of Mental Health
  Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Data Science Research: Personal Health Libraries for Consumers and Patients (R01)
  (PAR-17-159)
  National Library of Medicine
  Application Receipt/Submission Date(s): May 1, 2017; March 19, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• IDeA Networks of Biomedical Research Excellence (INBRE) (P20)
  (PAR-17-160)
  National Institute of General Medical Sciences
  Application Receipt/Submission Date(s): April 14, 2017; March 27, 2018; March 27, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• NCMRR Early Career Research Award (R03)
  (PAR-17-161)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt/Submission Date(s): April 21, 2017, March 30, 2018, March 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33)
  (PAR-17-162)
  National Center for Complementary and Integrative Health
  Application Receipt/Submission Date(s): New and revision applications are due June 1, 2017; February 1, 2018; October 1, 2018; May 31, 2019 , by 5:00 PM local time of applicant organization. Resubmission applications are due on June 20, 2017;
• Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program
• Biomarkers: Bridging Pediatric and Adult Therapeutics (R21)
  (PAR-17-169)
  Eunice Kennedy ShriverNational Institute of Child Health and Human Development
  Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Alcohol Research Resource Awards (R24)
  (PAR-17-170)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01)
  (PAR-17-171)
  National Cancer Institute
  Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

• NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01)
  (PAR-17-184)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt/Submission Date(s): October 18, 2017; June 19, 2018; February 20, 2019; October 18, 2019; June 18, 2020; by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.